GlassScriptPhysician profile
Brieda Staunton
NPI 1043956402
$2,460.23
in general payments reported to CMS, 2019-2025
27 companies · $730 in 2025
The $730 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $596 · 2023: $533 · 2024: $601 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.95 |
| Education | $132.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $554.36 | 2022 | |
| Novo Nordisk INC | $375.11 | 2023-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $324.57 | 2024-2025 | |
| Astellas Pharma US INC | $173.87 | 2024-2025 | Veozah |
| Abbvie INC. | $146.98 | 2023-2025 | |
| Organon LLC | $117.61 | 2023-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $98.87 | 2023-2024 | |
| Pfizer INC. | $90.08 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $71.95 | 2024 | Myfembree, Gemtesa |
| Coopersurgical, INC. | $66.32 | 2024-2025 | Paragard T 380a |
| Exact Sciences Corporation | $46.79 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Agile Therapeutics, INC. | $44.09 | 2024 | Twirla |
| Lilly USA, LLC | $43.80 | 2023-2024 | Mounjaro, Zepbound |
| Exeltis, USA INC. | $37.25 | 2023 | Slynd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.14 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $26.54 | 2023 | Ultomiris |
| Puma Biotechnology, INC. | $25.43 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.87 | 2025 | Exparel |
| Shield Therapeutics INC | $24.75 | 2024 | |
| Hologic Sales and Service, LLC | $21.67 | 2024 | Aptima |
| Amgen INC. | $21.10 | 2024 | Evenity, Prolia |
| Immunocore Limited | $20.28 | 2025 | Kimmtrak |
| Genzyme Corporation | $16.88 | 2025 | |
| Currax Pharmaceuticals LLC | $14.68 | 2022 | |
| Endo Pharmaceuticals INC. | $14.59 | 2022 | |
| Dendreon Pharmaceuticals LLC | $13.26 | 2024 | Provenge |
| Braintree Laboratories, INC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brieda Staunton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.